Shionogi & Co., Ltd. Unsponsored ADR (SGIOY) to Release Earnings on Monday

Key Points

• Shionogi will release quarterly results on Monday, May 11; analysts forecast EPS $0.15 and revenue of about $895.5 million, with consensus EPS of $1 for both the current and next fiscal year.
• In the prior quarter the company beat estimates, reporting $0.28 EPS versus $0.19 expected and $966.53 million in revenue versus $848.42 million, with a 41.82% net margin and 13.70% ROE.
• Shares were trading around $9.86 with a $16.78 billion market cap and a PE of 12.97; analyst sentiment is weak (average rating "Reduce") following recent downgrades and a one Hold/one Sell split.

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY - Get Free Report) will likely be posting its resultson Monday, May 11th. Analysts expect Shionogi & Co., Ltd. Unsponsored ADR to post earnings of $0.15 per share and revenue of $895.5180 million for the quarter.

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY - Get Free Report) last released its earnings results on Friday, January 30th. The company reported $0.28 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.19 by $0.09. The firm had revenue of $966.53 million for the quarter, compared to analyst estimates of $848.42 million. Shionogi & Co., Ltd. Unsponsored ADR had a return on equity of 13.70% and a net margin of 41.82%. On average, analysts expect Shionogi & Co., Ltd. Unsponsored ADR to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Shionogi & Co., Ltd. Unsponsored ADR Stock Performance

SGIOY remained flat at $9.86 during midday trading on Monday. The company's stock had a trading volume of 10,340 shares, compared to its average volume of 98,851. The stock has a market capitalization of $16.78 billion, a PE ratio of 12.97, a P/E/G ratio of 0.73 and a beta of 0.10. The firm has a fifty day simple moving average of $10.74 and a two-hundred day simple moving average of $9.69. The company has a debt-to-equity ratio of 0.01, a quick ratio of 5.21 and a current ratio of 5.84. Shionogi & Co., Ltd. Unsponsored ADR has a 12-month low of $7.38 and a 12-month high of $12.00.

Wall Street Analyst Weigh In

A number of analysts have issued reports on the company. The Goldman Sachs Group raised Shionogi & Co., Ltd. Unsponsored ADR to a "hold" rating in a report on Wednesday, April 8th. Zacks Research lowered Shionogi & Co., Ltd. Unsponsored ADR from a "hold" rating to a "strong sell" rating in a report on Thursday, April 16th. One equities research analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company's stock. According to MarketBeat.com, Shionogi & Co., Ltd. Unsponsored ADR presently has an average rating of "Reduce".

Shionogi & Co., Ltd. Unsponsored ADR Company Profile

Shionogi & Co, Ltd. is a Japan-based pharmaceutical company that conducts research, development, manufacturing and marketing of prescription drugs and vaccines. Established in the late 19th century, the company has expanded its focus beyond domestic markets to become a global player in pharmaceuticals, with particular expertise in anti-infectives, pain management, cardiovascular and central nervous system disorders.

The company's product portfolio spans both established and innovative therapies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.